MONROVIA, Calif., July 29, 2009 /PRNewswire-FirstCall via COMTEX/ -- STAAR Surgical Company (Nasdaq: STAA), a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced that Barry G. Caldwell, President and Chief Executive Officer will present at the BMO Capital Markets 9th Annual Focus on Healthcare Conference at the Millennium Broadway Hotel on Wednesday, August 5th at 4:00 pm Eastern Time.

Interested parties can access a live audio web cast of the presentation at www.staar.com. A replay of the presentation will be available at the same location.

About STAAR Surgical

STAAR Surgical is a leader in the development, manufacture and marketing of minimally invasive ophthalmic products employing proprietary technologies. STAAR's products are used by ophthalmic surgeons and include the Visian(R) ICL, a tiny, flexible lens implanted to correct refractive errors, as well as innovative products designed to improve patient outcomes for cataracts and glaucoma. Manufactured in Switzerland by STAAR, the ICL is approved by the FDA for use in treating myopia, has received CE Marking and is sold in more than 50 countries. Collamer(R) is the brand name for STAAR's proprietary collagen copolymer lens material. More information is available at www.staar.com.

    CONTACT:  Investors                       Media
              EVC Group                       EVC Group
              Douglas Sherk, 415-896-6820     Chris Gale 646-201-5431
              Mike Pollock, 415-896-6820

SOURCE STAAR Surgical Company

http://www.staar.com